A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice.
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2015
At a glance
- Drugs Cetuximab (Primary) ; Antineoplastics
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms RESECT
- Sponsors Merck KGaA
- 29 Mar 2014 Ac cording to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 02 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 13 Dec 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.